HealthDay Reports: FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19

June 15, 2020
Healthday News
blue coronavirus face mask surrounded by multicolored pills, a stethoscope and a needle and syringe

The FDA now says the drugs should not be used outside of clinical trials.

FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19

MONDAY, June 15, 2020 (HealthDay News) -- The U.S. Food and Drug Administration has withdrawn its emergency authorization for the use of two malaria drugs championed by President Donald Trump in the fight against COVID-19.

The agency said in a letter Monday that the drugs, hydroxychloroquine and chloroquine, are "unlikely to be effective" as treatments for the coronavirus, The New York Times reported.

The FDA now says the drugs should not be used outside of clinical trials.

Read the full HealthDay story.